About angiodynamics inc. - ANGO
AngioDynamics, Inc. is a medical device company, which engages in the development, manufacturing, and sale of medical devices for vascular access, surgery, peripheral vascular disease, and oncology. The firm offers ablation systems, fluid management systems, vascular access, angiographic, drainage, thrombolytic, and venous products. It operates through the Med Tech and Med Device segments. The Med Tech segment consists of technology portfolio including Auryon, the thrombus management platform and NanoKnife. The Med Device segment focuses on core, venous, ports, and other oncology products. The company was founded by Howard S. Stern and Eamonn P. Hobbs on February 9, 1988 and is headquartered in Latham, NY.
ANGO At a Glance
AngioDynamics, Inc.
14 Plaza Drive
Latham, New York 12110
| Phone | 1-518-795-1400 | Revenue | 320.17M | |
| Industry | Medical Specialties | Net Income | -36,742,000.00 | |
| Sector | Health Technology | 2026 Sales Growth | 9.462% | |
| Fiscal Year-end | 05 / 2027 | Employees | 632 | |
| View SEC Filings |
ANGO Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 1.489 |
| Price to Book Ratio | 2.802 |
| Price to Cash Flow Ratio | 154.33 |
| Enterprise Value to EBITDA | -378.213 |
| Enterprise Value to Sales | 1.355 |
| Total Debt to Enterprise Value | 0.025 |
ANGO Efficiency
| Revenue/Employee | 506,604.43 |
| Income Per Employee | -58,136.076 |
| Receivables Turnover | 6.60 |
| Total Asset Turnover | 1.17 |
ANGO Liquidity
| Current Ratio | 2.183 |
| Quick Ratio | 1.481 |
| Cash Ratio | 0.721 |
ANGO Profitability
| Gross Margin | 51.288 |
| Operating Margin | -6.974 |
| Pretax Margin | -11.338 |
| Net Margin | -11.476 |
| Return on Assets | -13.426 |
| Return on Equity | -20.77 |
| Return on Total Capital | -20.212 |
| Return on Invested Capital | -20.124 |
ANGO Capital Structure
| Total Debt to Total Equity | 6.414 |
| Total Debt to Total Capital | 6.027 |
| Total Debt to Total Assets | 4.101 |
| Long-Term Debt to Equity | 5.421 |
| Long-Term Debt to Total Capital | 5.094 |